Nanobiotix reported total assets of $146.58M and total liabilities of $184.71M for the quarter ended Jun 2026, up 57.9% year over year. This balance sheet covers 14 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Dec2018 | Dec2019 | Dec2020 | Jun2021 | Dec2021 | Jun2022 | Dec2022 | Jun2023 | Dec2023 | Jun2024 | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||
| Current Assets | ||||||||||||||
| Cash & EquivalentsCash & Equiv. | 41.42M | 39.31M | 146.55M | 121.80M | 95.04M | 65.84M | 44.12M | 23.51M | 83.32M | 71.03M | 51.76M | 33.80M | 61.97M | 126.67M |
| Short-term InvestmentsInvestments (Current) | 146.55M | 134.94M | 44.12M | 23.51M | 83.32M | 51.76M | 58.33M | 61.97M | 60.25M | |||||
| Cash & Current Investments | 41.42M | 39.31M | 293.11M | 121.80M | 229.98M | 65.84M | 88.25M | 47.01M | 166.65M | 71.03M | 103.51M | 92.13M | 123.93M | 186.92M |
| Receivables - NetNet Receivables | 0.01M | 0.08M | 0.25M | 0.11M | 1.18M | 1.00M | 3.34M | 3.12M | 2.15M | 2.51M | 2.21M | |||
| Receivables - OtherOther Receivables | 2.28M | |||||||||||||
| Receivables | 0.01M | 0.08M | 0.25M | 0.11M | 1.18M | 3.28M | 3.34M | 3.12M | 2.15M | 2.51M | 2.21M | |||
| Prepaid Assets | 12.35M | 7.42M | 16.11M | 10.35M | 10.03M | 11.59M | 11.86M | 10.06M | 11.78M | 9.11M | 10.83M | 9.24M | 12.17M | |
| Current Assets | 48.79M | 51.67M | 154.05M | 137.91M | 105.39M | 76.11M | 55.82M | 36.55M | 96.67M | 86.16M | 63.96M | 46.78M | 73.71M | 141.04M |
| Non-Current Assets | ||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 9.59M | 10.51M | 10.15M | 8.97M | 9.27M | 7.74M | 7.59M | 7.05M | 6.92M | 6.33M | 5.76M | 5.70M | 5.36M | 5.04M |
| Intangibles | 0.12M | 0.18M | 0.03M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.02M | 0.01M | 0.01M |
| Goodwill & Intangibles | 0.12M | 0.18M | 0.03M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | 0.01M | 0.01M | 0.02M | 0.01M | 0.01M |
| Non-Current Assets | 4.05M | 11.29M | 10.80M | 9.58M | 9.86M | 8.11M | 7.90M | 7.37M | 7.26M | 6.66M | 6.19M | 6.20M | 5.89M | 5.54M |
| Assets | 52.85M | 62.96M | 164.86M | 147.48M | 115.25M | 84.22M | 63.72M | 43.91M | 103.93M | 92.82M | 70.16M | 52.98M | 79.60M | 146.58M |
| Liabilities | ||||||||||||||
| Current Liabilities | ||||||||||||||
| Accounts Payables | 8.70M | 8.74M | 10.49M | 7.34M | 9.66M | 10.26M | 18.16M | 20.19M | 20.49M | 20.85M | 13.65M | 10.71M | 10.02M | |
| Notes Payables | 3.73M | 6.32M | 5.88M | 5.54M | 6.31M | 0.72M | 0.45M | 0.50M | 0.85M | 0.87M | ||||
| Payables | 8.70M | 12.47M | 16.81M | 13.22M | 9.66M | 15.79M | 24.47M | 20.90M | 20.49M | 21.30M | 14.15M | 11.57M | 10.89M | |
| Accumulated Expenses | -0.39M | -0.95M | -4.39M | |||||||||||
| Other Accumulated Expenses | 5.96M | 8.64M | 6.56M | 5.98M | 7.70M | 7.31M | 6.71M | 8.44M | 7.79M | 7.85M | 8.21M | 8.73M | 6.36M | |
| Short term Debt | 1.22M | 5.99M | 8.01M | 9.29M | 9.51M | 4.86M | 10.84M | 5.56M | 5.35M | 5.12M | 5.55M | 5.06M | 36.62M | |
| Current Leases | 1.47M | 1.42M | 1.36M | 1.20M | 1.25M | 1.33M | 1.31M | 1.46M | 1.42M | 1.41M | ||||
| Current Deferred Revenue | 19.70M | 18.71M | 17.43M | 0.06M | 0.15M | 0.14M | 0.11M | 0.06M | 0.06M | 0.05M | ||||
| Total Current Liabilities | 13.27M | 16.07M | 23.42M | 45.27M | 41.73M | 44.48M | 40.44M | 54.18M | 55.20M | 60.52M | 61.33M | 73.93M | 67.56M | 98.15M |
| Non-Current Liabilities | ||||||||||||||
| Non-Current Debt | 22.90M | 48.66M | 54.25M | 52.35M | 42.83M | 37.61M | 51.82M | 47.85M | 50.41M | 47.30M | 47.85M | 54.54M | 106.91M | 85.15M |
| Non-Current Deffered Revenue | 7.94M | |||||||||||||
| Pension | -0.05M | -0.04M | -0.04M | -0.04M | -0.05M | -0.04M | ||||||||
| Operating Leases | 7.15M | 5.94M | 6.11M | 5.75M | 4.96M | 5.06M | 1.35M | 4.52M | 0.51M | 2.97M | ||||
| Other Non-Current Liabilities | 28.91M | 4.81M | 3.78M | 3.77M | ||||||||||
| Total Non-Current Liabilities | 23.29M | 49.03M | 54.76M | 52.90M | 43.19M | 37.87M | 52.11M | 48.18M | 50.77M | 55.62M | 77.20M | 59.91M | 111.29M | 86.56M |
| Total Liabilities | 65.10M | 78.18M | 98.17M | 84.91M | 82.35M | 92.55M | 102.37M | 105.97M | 116.14M | 138.53M | 133.84M | 178.84M | 184.71M | |
| Shareholder's Equity | ||||||||||||||
| Total Debt | 22.90M | 49.88M | 63.97M | 66.68M | 61.37M | 47.12M | 64.62M | 67.45M | 59.18M | 52.65M | 54.73M | 61.49M | 112.99M | 122.76M |
| Common Equity | -2.14M | 86.67M | 49.31M | 30.34M | 1.87M | -28.83M | -58.45M | -2.04M | -23.32M | -68.37M | -80.86M | -99.24M | -38.13M | |
| Liabilities and Shareholders Equity | 52.85M | 62.96M | 164.86M | 147.48M | 115.25M | 84.22M | 63.72M | 43.91M | 103.93M | 92.82M | 70.16M | 52.98M | 79.60M | 146.58M |
| Treasury Shares | 0.19M | 0.24M | 0.25M | 0.23M | 0.25M | 0.24M | 0.25M | 0.25M | 0.24M | 0.24M | 0.27M | 0.27M | 0.26M | |
| Retained Earnings | -57.04M | -41.32M | -36.21M | -207.77M | -239.33M | -242.30M | -307.57M | -306.38M | -336.86M | -395.85M | -6.31M | -470.83M | -39.16M |
Pull Nanobiotix's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=NBTX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "NBTX", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=NBTX&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();